Beckley Psytech logo

Beckley Psytech

Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions.

68 employees · est. 2019 · Oxford, United Kingdom

VS
Diamond Therapeutics logo

Diamond Therapeutics

Revolutionizing the treatment of mental health

9 employees · est. 2018 · Toronto, Canada

Diamond Therapeutics is the older company (2019 vs 2018); Beckley Psytech is the larger of the two.

Side-by-Side Comparison

Beckley Psytech Diamond Therapeutics
Founded
2019 2018 older
Headquarters
Oxford, United Kingdom Toronto, Canada
Employees
68 larger 9
Industry
Not tracked yet Biotechnology, Health Care, Health and Wellness
Funding Stage
Merged Series Unknown
Total Funding
$114.55M Not tracked yet
Funding Rounds
5 2
Services
Developing mental health treatments, Conducting clinical trials, Empathy-driven patient care Not tracked yet
Target Customers
Individuals with mental health conditions, Healthcare providers, Investors interested in mental health solutions Not tracked yet
Taxonomy
Psychedelic Medicine, Neuropsychiatric Disorders, Clinical-stage, Psilocybin, Drug Development, Mental Health Treatment, Rapid-acting Medicines, Depression Treatment, Scientific Research, Therapeutic Potential, Modern Medical Practice, Patient Outcomes Optimization, Beckley Foundation Research Psychopharmacology, Life Sciences, Neuropsychiatry, Drug Development, Clinical Trials, Clinical Drug Development, Psychedelic Medicine
Website
beckleypsytech.com diamondthera.com
Beckley Psytech logo

About Beckley Psytech

Beckley Psytech is a pioneering, clinical-stage biotechnology company founded in 2019 and headquartered in the United Kingdom. With a clear mission of "Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions," the company is focused on leveraging decades o...

Diamond Therapeutics logo

About Diamond Therapeutics

Diamond Therapeutics is a biotechnology startup headquartered in Canada, founded in 2018. The company is revolutionizing the treatment of mental health through the development of safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. Their focus is on sub-perceptual ps...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Beckley Psytech and Diamond Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Beckley Psytech and Diamond Therapeutics — by email.

Frequently Asked Questions

Beckley Psytech — Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions.. Diamond Therapeutics — Revolutionizing the treatment of mental health . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Beckley Psytech has raised $114.55M while Diamond Therapeutics has raised undisclosed funding.
Beckley Psytech and Diamond Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Beckley Psytech with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy